J. Nordlund

发表

Analysis of the UV-induced melanogenesis and growth arrest of human melanocytes.

G. Babcock, V. Swope, Z. Abdel‐Malek, 1994, Pigment cell research.

Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.

Susan C. Taylor, J. Ortonne, L. Hynan, 2011, Journal of the American Academy of Dermatology.

Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.

J. Kirkwood, J. Nordlund, D. Albert, 1985, Cancer research.

The Pigmentary System: Physiology and Pathophysiology: Second Edition

James J. Nordlund, Richard A. King, Vincent J. Hearing, 2007 .

What are melanocytes really doing all day long…?

J. Ortonne, D. Tobin, R. Paus, 2009, Experimental dermatology.

Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1992, Journal of cellular physiology.

Successful culture of adult human melanocytes obtained from normal and vitiligo donors.

E. Medrano, J. Nordlund, 1990, The Journal of investigative dermatology.

Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation.

M. B. Davis, G. Babcock, Z. Abdel‐Malek, 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Personal responses of patients to vitiligo: the importance of the patient-physician interaction.

J. Nordlund, A. Lerner, J. Porter, 1978, Archives of dermatology.

The prevalence of vitiligo and poliosis in patients with uveitis.

J. Nordlund, D. Albert, A. Lerner, 1981, Journal of the American Academy of Dermatology.

Response to cosmetic disfigurement: patients with vitiligo.

J. Nordlund, A. Lerner, J. Porter, 1987, Cutis.

The natural history of dysplastic nevi. A case history illustrating their evolution.

J. Nordlund, L. Barnes, 1987, Archives of dermatology.

Management of vitiligo.

J. Nordlund, P. Grimes, R. Halder, 1993, Dermatologic clinics.

Guidelines of care for vitiligo. American Academy of Dermatology.

M. Turner, J. Nordlund, E. Farmer, 1996, Journal of the American Academy of Dermatology.

The pigmentary system : physiology and pathophysiology

J. Nordlund, 1998 .

On the causes of melanomas.

J. Nordlund, A. Lerner, 1977, American Journal of Pathology.

Vitiligo in patients with metastatic melanoma: a good prognostic sign.

J. Kirkwood, J. Nordlund, D. Albert, 1983, Journal of the American Academy of Dermatology.

Isolation of a unique melanogenic inhibitor from human skin xenografts: initial in vitro and in vivo characterization.

S. Boyce, J. Nordlund, G. Warden, 1995, Journal of Investigative Dermatology.

Confusions about color: formulating a more precise lexicon for pigmentation, pigmentary disorders, and abnormalities of "chromatics".

J. Ortonne, J. Nordlund, T. Cestari, 2006, Journal of the American Academy of Dermatology.

The effects of oral melatonin on skin color and on the release of pituitary hormones.

J. Nordlund, A. Lerner, 1977, The Journal of clinical endocrinology and metabolism.

Supermelanotic hybrids derived from mouse melanomas and normal mouse cells

U. Francke, R. Halaban, J. Nordlund, 1980, Somatic cell genetics.

Multiple topical applications of arachidonic acid to mouse ears induce inflammatory and proliferative changes.

J. Nordlund, L. Rheins, N. Doherty, 1988, The Journal of investigative dermatology.

Genetic Basis of Pigmentation and Its Disorders

J. Nordlund, L. Klein, 1981, International journal of dermatology.

The nature and biological effects of factors responsible for proliferation and differentiation of melanocytes.

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1990, Pigment cell research.

Hormonal effects of vitamin D3 on epidermal melanocytes

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1988, Journal of cellular physiology.

Vitiligo: current medical and scientific understanding.

J. Nordlund, R. Boissy, 2011, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

Alterations in cutaneous immune reactivity to dinitrofluorobenzene in graying C57BL/vi.vi mice.

J. Nordlund, L. Rheins, M. Palkowski, 1986, The Journal of investigative dermatology.

Immune studies in the depigmenting C57BL/Ler-vit/vit mice. An apparent isolated loss of contact hypersensitivity.

J. Nordlund, S. Amornsiripanitch, L. Rheins, 1988, Journal of immunology.

A method for quantifying Langerhans cells in epidermal sheets of human and murine skin.

J. Nordlund, A. Ackles, 2008, Tissue Antigens.

Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".

R. Sturm, J. Nordlund, V. Hearing, 1996, American journal of human genetics.

Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.

H. van Loveren, Y. Ron, P. Askenase, 1983, Journal of immunology.

Dilated rough endoplasmic reticulum and premature death in melanocytes cultured from the vitiligo mouse.

J. Nordlund, R. Boissy, K. E. Beato, 1991, The American journal of pathology.

Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo.

J. Nordlund, A. Lerner, G. Moellmann, 1982, The Journal of investigative dermatology.

STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN

J. Nordlund, S. Wolff, R. Root, 1970, The Journal of experimental medicine.

Human TRP-1 has tyrosine hydroxylase but no dopa oxidase activity.

J. Nordlund, R. Boissy, H. Zhao, 1994, Pigment cell research.

The epidemiology and genetics of vitiligo.

J. Nordlund, 1997, Clinics in dermatology.

Chronic growth stimulation of human adult melanocytes by inflammatory mediators in vitro: implications for nevus formation and initial steps in melanocyte oncogenesis.

E. Medrano, J. Nordlund, R. Boissy, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity.

J. Nordlund, L. Rheins, 1986, Journal of immunology.

Separation of pigmented and albino melanocytes and the concomitant evaluation of endogenous peroxide content using flow cytometry.

J. Nordlund, R. Boissy, L. Trinkle, 1989, Cytometry.

Vitiligo: It Is Important

J. Nordlund, A. Lerner, 1982 .

Identification and sequencing of a putative variant of proopiomelanocortin in human epidermis and epidermal cells in culture.

S. Boyce, Z. Abdel‐Malek, J. Nordlund, 1998, The Journal of investigative dermatology.

The Expression of Proopiomelanocortin and Various POMC‐Derived Peptides in Mouse and Human Skin

Z. Abdel‐Malek, E. Medrano, J. Nordlund, 1993, Annals of the New York Academy of Sciences.

Thy‐1 + dendritic cells express truncated form of POMC mRNA

E. Medrano, J. Nordlund, R. Boissy, 1995, Experimental dermatology.

Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice.

J. Nordlund, L. Rheins, W. B. Hoppenjans, 1989, The Journal of investigative dermatology.

The multiple lentigines syndrome.

J. Nordlund, I. Braverman, A. Lerner, 1973, Archives of dermatology.

A recurrent deletion in the KIT (mast/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism.

R. Spritz, J. Nordlund, K. Fukai, 1993, Human molecular genetics.

The Medical Treatment of Vitiligo: An Historical Review.

J. Nordlund, 2017, Dermatologic clinics.

VITILIGO: A REVIEW OF SOME FACTS LESSER KNOWN ABOUT DEPIGMENTATION

J. Nordlund, 2011, Indian journal of dermatology.

The significance of depigmentation.

J. Nordlund, 2008, Pigment cell research.

Vitiligo and depigmentation

J. Ortonne, J. Nordlund, 1992 .

Hypopigmentation, vitiligo, and melanoma. New data, more enigmas.

J. Nordlund, 1987, Archives of dermatology.

Periodic synopsis on pigmentation.

A. Sober, J. Nordlund, T. W. Hansen, 1985, Journal of the American Academy of Dermatology.

Vitiligo or halo nevi occurring in two patients with choroidal melanoma.

J. Nordlund, D. Albert, N. Todes-Taylor, 1982, Archives of dermatology.

Anti-pigment-cell factors and mucocutaneous candidiasis.

J. Nordlund, J. Bystryn, A. Lerner, 1981, Archives of dermatology.

Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.

J. Nordlund, A. Lerner, M. Mitchell, 1980, The Journal of investigative dermatology.

Should vitiligo be induced in patients after resection of primary melanoma.

J. Nordlund, A. Lerner, 1977, Archives of dermatology.

The pigmentary system and inflammation.

J. Nordlund, 1992, Pigment cell research.

Interleukins 1α and 6 and tumor necrosis factor-α are paracrine inhibitors of human melanocyte proliferation and melanogenesis

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1991 .

Melatonin: clinical pharmacology.

J. Nordlund, A. Lerner, 1978, Journal of neural transmission. Supplementum.

Low ICAM‐1 expression in the epidermis of depigmenting C57BL/6J‐mivit/mivit mice: A possible cause of muted contact sensitization

G. Babcock, J. Nordlund, F. Takei, 1995, Experimental dermatology.

Role of the Melanocyte in Epidermal Inflammatory and Immune Responses

Z. Abdel‐Malek, J. Nordlund, R. Boissy, 1988 .

Ocular pathology in the minimally depigmented subline of the vitiliginous Smyth chicken.

J. Nordlund, R. Boissy, J. Smyth, 1988, Pigment cell research.

Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.

J. Nordlund, M. Nordlund, L. Rheins, 1987, Archives of dermatology.

Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2.

J. Nordlund, S. Amornsiripanitch, C. E. Collins, 1987, Cellular immunology.

Dermatitis produced by applications of monobenzone in patients with active vitiligo.

J. Kirkwood, J. Nordlund, A. Lerner, 1985, Archives of dermatology.

Vitiligo and melanoma.

J. Nordlund, A. Lerner, 1979, Archives of dermatology.

Severe vinblastine-induced leukopenia during late pregnancy with delivery of a normal infant.

V. Devita, J. Nordlund, P. P. Cabbone, 1968, Annals of internal medicine.

The effect of vitiligo on sexual relationships.

J. Nordlund, A. Lerner, J. Porter, 1990, Journal of the American Academy of Dermatology.

Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders.

J. Nordlund, A. Lerner, J. Porter, 1986, Journal of the American Academy of Dermatology.

Cutaneous ectoparasites

J. Nordlund, 2009, Dermatologic therapy.

Oral examination

Stafford, J. Nordlund, D. Lynch, 2000, Nature medicine.

In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins.

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1987, Cancer research.

Hyperpigmentation: Its Historical Treatment and the Development of Hydroquinone

J. Nordlund, 2015 .

THE PIGMENTARY SYSTEM

James J. Nordlund, J. Nordlund, 1985 .

Increasing our understanding of pigmentary disorders.

Susan C. Taylor, J. Nordlund, P. Grimes, 2006, Journal of the American Academy of Dermatology.

Hydroa vacciniforme: diagnosis and therapy.

M. Goldgeier, J. Nordlund, A. Lucky, 1982, Archives of dermatology.

New therapy for polymorphous light eruption.

J. Nordlund, M. Mathews-Roth, M. Pathak, 1973, Archives of dermatology.

The effects of ultraviolet light and certain drugs on La-bearing Langerhans cells in murine epidermis.

J. Nordlund, A. Lerner, A. Ackles, 1981, Cellular immunology.

Vitiligo: What Is It? Is It Important?

J. Nordlund, A. Lerner, 1978 .

New observations on vitiligo and ocular disease.

J. Kirkwood, J. Nordlund, D. Albert, 1983, American journal of ophthalmology.

Ocular abnormalities occurring with vitiligo.

J. Nordlund, D. Albert, A. Lerner, 1979, Ophthalmology.

Halo nevi and the Vogt-Koyanagi-Harada syndrome. Manifestations of vitiligo.

J. Nordlund, D. Albert, A. Lerner, 1980, Archives of dermatology.

The MAGIC syndrome (mouth and genital ulcers with inflamed cartilage).

J. Nordlund, T. Brown, R. Orme, 1990, Archives of dermatology.

Psychological reaction to chronic skin disorders: a study of patients with vitiligo.

J. Nordlund, A. Lerner, J. Porter, 1979, General Hospital Psychiatry.

The distribution of melanocytes in the leptomeninges of the human brain.

M. Goldgeier, J. Nordlund, L. Klein, 1984, The Journal of investigative dermatology.

Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuation.

J. Nordlund, M. Heffernan, L. Morrison, 2009, Dermatology online journal.

Vitiligo. What is it? Is it important?

J. Nordlund, A. Lerner, 1978, JAMA.

Successful treatment of a patient with Reiter's syndrome and acquired immunodeficiency syndrome using etretinate.

J. Nordlund, A. Solinger, D. Breneman, 1989, Journal of the American Academy of Dermatology.

Postinflammatory hyperpigmentation.

J. Nordlund, 1988, Dermatologic clinics.

Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse.

J. Nordlund, C. E. Collins, L. Rheins, 1986, The Journal of investigative dermatology.

The melanocyte and the epidermal melanin unit: an expanded concept.

J. Nordlund, 2007, Dermatologic clinics.

Cutaneous T-cell lymphoma sparing resolving dermatomal herpes zoster lesions: an unusual phenomenon and implications for pathophysiology.

J. Nordlund, J. Twersky, 2004, Journal of the American Academy of Dermatology.

The lives of pigment cells.

J. Nordlund, James J. Nordlund, 1986, Clinics in geriatric medicine.

Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis.

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1991, The Journal of investigative dermatology.

Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation.

G. Babcock, Z. Abdel‐Malek, E. Medrano, 1998, Cancer research.

Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis.

R. Cone, Z. Abdel‐Malek, J. Nordlund, 1996, Endocrinology.

Definition of Vitiligo

J. Nordlund, S. Hann, 2008 .

Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes.

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1993, Journal of cell science.

Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients.

E. Medrano, J. Nordlund, R. Boissy, 1991, The Journal of investigative dermatology.

Clinical Features of Generalized Vitiligo

J. Nordlund, S. Hann, 2008 .

Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation.

J. Nordlund, W. Oetting, R. Boissy, 1999, Pigment cell research.

Smyth chicken melanocyte autoantibodies: cross-species recognition, in vivo binding, and plasma membrane reactivity of the antiserum.

J. Nordlund, R. Boissy, H. Zhao, 1993, Pigment cell research.

Proceedings of the First International Workshop on Vitiligo

J. Nordlund, A. Lerner, J. A. Kenney, 1978 .

Vitiligo and Other Hypomelanosis of Hair and Skin

J. Nordlund, 1985 .

Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site.

V. Swope, Z. Abdel‐Malek, E. Medrano, 1994, Pigment cell research.

Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1989, Experimental cell research.

Alteration of the Cloudman melanoma cell cycle by prostaglandins E1 and E2 determined by using a 5‐bromo‐2′‐deoxyuridine method of DNA analysis

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1988, Journal of cellular physiology.

On the cause of green hair.

J. Nordlund, J. Fister, C. Hartley, 1977, Archives of Dermatology.

Vitiligo. It is important.

J. Nordlund, A. Lerner, 1978, Archives of dermatology.

Vitiligo: a manifestation of apoptosis?

J. Nordlund, R. Boissy, Carol L. Huang, 2002, American journal of clinical dermatology.

VITILIGO: THE LOSS OF PIGMENT IN SKIN, HAIR AND EYES

J. Nordlund, A. Lerner, 1978, The Journal of dermatology.

Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.

G. Barsh, M. Ollmann, Z. Abdel‐Malek, 1997, The Journal of investigative dermatology.

Uveal Melanocytes Do Not Respond To or Express Receptors for α-Melanocyte-Stimulating Hormone

D. Hu, S. Mccormick, J. Nordlund, 2006 .

Hyperpigmentation of human skin grafted on to athymic nude mice: immunohistochemical study

K. Matsumoto, J. Nordlund, G. Warden, 1996, The British journal of dermatology.

Terminal differentiation and senescence in the human melanocyte: repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes.

K. Matsumoto, E. Medrano, J. Nordlund, 1994, Molecular biology of the cell.

Unusual skin depigmentation following eyelid cryosurgery.

J. Nordlund, N. Zabriskie, J. Nerad, 1996, Ophthalmic Plastic and Reconstructive Surgery.

The proliferative and toxic effects of ultraviolet light and inflammation on epidermal pigment cells.

J. Nordlund, A. Ackles, F. Traynor, 1981, The Journal of investigative dermatology.

The vit gene maps to the mi (microphthalmia) locus of the laboratory mouse.

J. Nordlund, R. Boissy, J. Womack, 1992, The Journal of heredity.

Melagenina. An analysis of published and other available data.

J. Nordlund, R. Halder, 1990, Dermatologica.

On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes.

Z. Abdel‐Malek, J. Nordlund, R. Boissy, 1994, Laboratory investigation; a journal of technical methods and pathology.

Guidelines of care for vitiligo. American Academy of Dermatology.

M. Turner, J. Nordlund, E. Farmer, 1996, Journal of the American Academy of Dermatology.

Neural-tube-derived melanocyte subsets undergo commitment to their distinct lineages in culture.

J. Nordlund, R. Boissy, L. Trinkle, 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

Depigmentation: its significance in patients with melanoma.

J. Nordlund, L. Barnes, 1989, Clinics in dermatology.

Pigment cells of the eyes in people with vitiligo.

J. Nordlund, D. Albert, A. Lerner, 1977, New England Journal of Medicine.

Pigment cell biology: an historical review.

Z. Abdel‐Malek, J. Nordlund, R. Boissy, 1989, The Journal of investigative dermatology.

Vitiligo and disorders of the retinal pigment epithelium.

R. Pruett, J. Nordlund, D. Albert, 1983, The British journal of ophthalmology.

Leukoderma in the nude C57BL/6 mouse

J. Nordlund, A. Ackles, 1978, The British journal of dermatology.

Influence of depigmenting chemical agents on hair and skin color in yellow (pheomelanic) and black (eumelanic) mice.

W. C. Quevedo, T. Holstein, J. Nordlund, 1989, Pigment cell research.

Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.

V. Swope, Z. Abdel‐Malek, J. Nordlund, 1988, Cytometry.

Mechanisms That Cause Abnormal Skin Color

J. Ortonne, J. Nordlund, 2007 .

Quantitative factors which determine the effect of the immune response on the growth rate of the Cloudman Melanoma in the DBA/2 mice.

J. Nordlund, R. Gershon, A. Ackles, 1980, Cellular immunology.

Surface proteins on Cloudman melanoma cells.

J. Nordlund, R. Gershon, R. Cone, 1980, Cellular immunology.

Effects of oral contraceptives and pregnancy on melanomas.

J. Kirkwood, J. Nordlund, A. Lerner, 1979, The New England journal of medicine.

Hydroquinone: its value and safety. Commentary on the US FDA proposal to remove hydroquinone from the over-the-counter market

J. Nordlund, 2007 .

The safety of hydroquinone

J. Ortonne, J. Nordlund, P. Grimes, 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

Effects of various storage conditions and alterations of antioxidant contents on chromatic aberration of hydroquinone ointment.

M. Ichihashi, J. Nordlund, T. Fujita, 2003, Biological & pharmaceutical bulletin.

Molecular basis of congenital hypopigmentary disorders in humans: a review.

J. Nordlund, R. Boissy, James J. Nordlund, 1997, Pigment cell research.

Pharmaceutical and clinical assessment of hydroquinone ointment prepared by extemporaneous nonsterile compounding.

M. Hirai, M. Ichihashi, J. Nordlund, 2002, Biological & pharmaceutical bulletin.

Management of vitiligo in children.Symposium.

A. P. Kelly, J. Nordlund, P. Grimes, 1986, Pediatric dermatology.

Synthesis of Interleukin-1a and by Normal Human Melanocytes

G. Babcock, V. Swope, Z. Abdel‐Malek, 1994 .

Nonmelanoma skin cancer in vitiligo patients.

J. Nordlund, 2009, Journal of the American Academy of Dermatology.

Synthesis of interleukin-1 alpha and beta by normal human melanocytes.

G. Babcock, V. Swope, Z. Abdel‐Malek, 1994, The Journal of investigative dermatology.

Vitiligo, chronic thrombocytopenia, and autoimmune hemolytic anemia.

J. Nordlund, A. Lerner, T. Walters, 1978, Archives of dermatology.

Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation.

Z. Abdel‐Malek, J. Nordlund, 1988, Progress in clinical and biological research.

Physiological Alterations in the Depigmented Skin of Patients with Vitiligo

J. Nordlund, S. Im, 2008 .

Vitiligo : a monograph on the basic and clinical science

J. Nordlund, S. Hann, 2000 .

Depigmentation for the Treatment of Extensive Vitiligo

J. Nordlund, 2008 .

Pedigree analysis of vitiligo: Further support for multilocus involvement

P. Majumder, J. Nordlund, S. Nath, 1995, Journal Genetika.

Chapter 32. Genetic Hypomelanoses: Localized Hypopigmentation

R. Happle, J. Nordlund, J. Bolognia, 2007 .

Genetic Hypomelanoses: Generalized Hypopigmentation

P. Bahadoran, J. Ortonne, J. Nordlund, 2007 .

Uveal melanocytes do not respond to or express receptors for alpha-melanocyte-stimulating hormone.

D. Hu, S. Mccormick, J. Nordlund, 2006, Investigative ophthalmology & visual science.

The Loss of Melanocytes from the Epidermis: the Mechanism for Depigmentation of Vitiligo Vulgaris

J. Nordlund, 2008 .

Disorders of hypopigmentation.

J. Nordlund, 1978, Connecticut medicine.

Topical Treatment of Pigmentary Disorders

J. Nordlund, R. Halder, 2007 .

Ocular pathology in mice with a transgenic insertion at the microphthalmia locus.

J. Lingrel, J. Nordlund, R. Boissy, 1993, Journal of submicroscopic cytology and pathology.

pigment epithelium . Vitiligo and disorders of the retinal

R. Pruett, J. Nordlund, D. Albert, 2022 .

The Normal Color of Human Skin

James J. Nordlund, Jean-Paul Ortonne, J. Ortonne, 2007 .

The effect of histamine, antihistamines, and a mast cell stabilizer on the growth of cloudman melanoma cells in DBA/2 mice.

P. Askenase, J. Nordlund, 1983, The Journal of investigative dermatology.

Splenic regulation of the clinical appearance of small tumors.

J. Nordlund, R. Gershon, 1975, Journal of immunology.

Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.

S. Ariyan, J. Kirkwood, J. Nordlund, 1982, Surgery.

Exacerbation of Darier's disease by lithium carbonate.

J. Nordlund, J. DiGiovanna, G. Peck, 1990, Journal of the American Academy of Dermatology.

Morphogenesis of the Skin

J. Nordlund, 1977, The Yale Journal of Biology and Medicine.

Alpha-melanocyte-stimulating hormone. A ubiquitous cytokine with pigmenting effects.

J. Nordlund, 1991, JAMA.

Factors affecting the quantitative production and assay of human leukocytic pyrogen.

J. Nordlund, S. Wolff, R. Root, 1970, The Journal of laboratory and clinical medicine.

Basement membrane and fibroblast aberration in blisters at the donor, graft, and spontaneously healed sites in patients with burns.

J. Nordlund, R. Boissy, G. Warden, 1992, Archives of dermatology.

Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic mice.

S. Boyce, Z. Abdel‐Malek, E. Medrano, 1993, The Journal of investigative dermatology.

Rapid induction of Thy-1 antigenic markers on keratinocytes and epidermal immune cells in the skin of mice following topical treatment with common preservatives used in topical medications and in foods.

J. Nordlund, M. Nordlund, E. Young, 1987, The Journal of investigative dermatology.

The role of antioxidants in skin immune reactions: the use of flow cytometry to determine alterations in Ia-positive epidermal cells in allergic contact dermatitis

J. Nordlund, M. Nordlund, L. Rheins, 1989 .

Uveal findings in patients with cutaneous melanoma.

J. Kirkwood, P. Lavin, J. Kirkwood, 1983, American journal of ophthalmology.

The lives of pigment cells.

J. Nordlund, 1989, Dermatologic clinics.

Inhibition of Biologic Activity of Poly I: Poly C by Human Plasma

J. Nordlund, S. Wolff, H. Levy, 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Clinical appearance of cutaneous melanomas.

J. Nordlund, 1975, The Yale journal of biology and medicine.

Granulomatous lymphangitis. A complication of intralymphatic immunotherapy with methanol extraction residue of BCG (MER)

S. Ariyan, J. Kirkwood, J. Nordlund, 1982 .

Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma.

S. Gruber, J. Kirkwood, J. Nordlund, 1988, Preventive medicine.

Reproduction of hydroa vacciniforme with UVA.

M. Goldgeier, J. Nordlund, A. Lucky, 1983, Journal of the American Academy of Dermatology.

Successful topical treatment of an unusual ulcer with fluorouracil.

J. Nordlund, S. Klaus, 1972, Archives of dermatology.

Increased Gamma/Delta T Cells and Thy‐1 Cells in Cutaneous T Cell Lymphoma

D. Fivenson, J. Nordlund, E. Krull, 1991, Annals of the New York Academy of Sciences.